Literature DB >> 11027661

Kringle 1 of human hepatocyte growth factor inhibits bovine aortic endothelial cell proliferation stimulated by basic fibroblast growth factor and causes cell apoptosis.

L Xin1, R Xu, Q Zhang, T P Li, R B Gan.   

Abstract

Hepatocyte growth factor (HGF), also known as scatter factor, is a mesenchymal or stromal-derived mediator with angiogenic activity. There are four kringle domains in its amino terminus. They display considerable sequence similarity with those of angiostatin, an angiogenesis inhibitor. We now describe that the recombinant kringle1 of HGF (HGFK1) inhibits bovine aortic endothelial (BAE) cell proliferation stimulated by basic fibroblast growth factor in a dose-dependent manner, with an ED(50) of approximately 0.7 microg/ml, while ED(50) of angiostatin is 3 microg/ml. Treatment of BAE cell with HGFK1 caused cell apoptosis. This report thus constitutes the first demonstration that kringle1 of HGF is a selective inhibitor for BAE cell proliferation stimulated by bFGF. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027661     DOI: 10.1006/bbrc.2000.3658

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Cancer gene therapy targeting angiogenesis: an updated review.

Authors:  Ching-Chiu Liu; Zan Shen; Hsiang-Fu Kung; Marie C M Lin
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

2.  Construction of human liver cancer vascular endothelium cDNA expression library and screening of the endothelium-associated antigen genes.

Authors:  Xing Zhong; Yu-Liang Ran; Jin-Ning Lou; Dong Hu; Long Yu; Yu-Shan Zhang; Zhuan Zhou; Zhi-Hua Yang
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

3.  Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.

Authors:  David Berry; Zachary Shriver; Barbara Natke; Chi-Pong Kwan; Ganesh Venkataraman; Ram Sasisekharan
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

4.  A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.

Authors:  Yi Xu; Hui Zhao; Ying Zheng; Qing Gu; Jianxing Ma; Xun Xu
Journal:  Mol Vis       Date:  2010-10-07       Impact factor: 2.367

Review 5.  The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering.

Authors:  Abbas Mohajeri; Sarvin Sanaei; Farhad Kiafar; Amir Fattahi; Majid Khalili; Nosratollah Zarghami
Journal:  Adv Pharm Bull       Date:  2017-04-13

Review 6.  Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.

Authors:  Asbiel Hasbum; Jaqueline Quintanilla; Juan A Amieva Jr; May-Hui Ding; Arkene Levy; Sue Anne Chew
Journal:  Future Med Chem       Date:  2021-01-05       Impact factor: 3.808

7.  Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours.

Authors:  Alexandra Buhles; Sara A Collins; Jan P van Pijkeren; Simon Rajendran; Michelle Miles; Gerald C O'Sullivan; Deirdre M O'Hanlon; Mark Tangney
Journal:  Genet Vaccines Ther       Date:  2009-03-09

8.  High efficacy and minimal peptide required for the anti-angiogenic and anti-hepatocarcinoma activities of plasminogen K5.

Authors:  Xia Yang; Weibin Cai; Zumin Xu; Jing Chen; Chaoyang Li; Shaojun Liu; Zhonghan Yang; Qiuhui Pan; Mingtao Li; Jianxing Ma; Guoquan Gao
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

9.  H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma.

Authors:  Wenyan Zhang; Rui Duan; Jian Zhang; William K C Cheung; Xiaoge Gao; Raymond Zhang; Qing Zhang; Mengxue Wei; Gang Wang; Qian Zhang; Peng-Jin Mei; Hong-Lin Chen; Hsiangfu Kung; Marie C Lin; Zan Shen; Junnian Zheng; Longzhen Zhang; Hong Yao
Journal:  Br J Cancer       Date:  2018-01-18       Impact factor: 7.640

Review 10.  Updates on Gene Therapy for Diabetic Retinopathy.

Authors:  Jiang-Hui Wang; Georgina Eloise Roberts; Guei-Sheung Liu
Journal:  Curr Diab Rep       Date:  2020-05-16       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.